Literature DB >> 7642306

Effect of anti-tumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections.

P Mastroeni1, J N Skepper, C E Hormaeche.   

Abstract

We reported that administration of anti-tumor necrosis factor alpha (anti-TNF-alpha) antibodies exacerbates the course of a Salmonella infection in both susceptible and resistant mice by preventing the suppression of bacterial growth in the reticuloendothelial system. In the present study, we evaluated the effect of in vivo neutralization of TNF-alpha on the histopathology of primary Salmonella infections. We show that in primary infections, the suppression of bacterial growth in the reticuloendothelial system coincides with granuloma formation in the spleen and liver. Administration of anti-TNF-alpha globulins on day -1 of salmonellosis affected neither the histological picture nor the course of the infection in the early stages of the disease (days 1 to 3), with splenic and hepatic lesions consisting mainly of polymorphonuclear leukocytes (PMNs); conversely, later in infection (days 3 to 7), the treatment inhibited the formation of granulomas. When the anti-TNF-alpha treatment was started well after the suppression of bacterial growth in the reticuloendothelial system and the formation of granulomatous lesions in the spleen and liver, a prompt relapse of the infection and regression of already established granulomas were seen. In anti-TNF-alpha-treated mice, salmonellae were found inside macrophages and PMNs and extracellularly in the necrotic tissue of the spleen, while in the liver the organisms were seen mainly in inflammatory mononuclear cells, resident Kupffer cells, and hepatocytes and occasionally in the extracellular compartment within necrotic lesions. The bacteria appeared most often in clusters, being morphologically intact when in the extracellular space or within hepatocytes, while undergoing various degrees of degeneration when inside phagocytes. The results suggest that TNF-alpha is required for granuloma formation in salmonellosis and that its neutralization does not completely abrogate the bactericidal activity of macrophages and PMNs. Salmonellae were observed to grow within both hepatocytes and phagocytes but were killed only in the latter.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7642306      PMCID: PMC173509          DOI: 10.1128/iai.63.9.3674-3682.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  The initial suppression of bacterial growth in a salmonella infection is mediated by a localized rather than a systemic response.

Authors:  D J Maskell; C E Hormaeche; K A Harrington; H S Joysey; F Y Liew
Journal:  Microb Pathog       Date:  1987-04       Impact factor: 3.738

Review 2.  Vaccines and cell-mediated immunity.

Authors:  F M Collins
Journal:  Bacteriol Rev       Date:  1974-12

3.  Electron microscopic studies on the location of bacterial proliferation in the liver in murine salmonellosis.

Authors:  F R Lin; X M Wang; H S Hsu; V R Mumaw; I Nakoneczna
Journal:  Br J Exp Pathol       Date:  1987-08

4.  Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes.

Authors:  W J Ming; L Bersani; A Mantovani
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

5.  Natural resistance to Salmonella typhimurium in different inbred mouse strains.

Authors:  C E Hormaeche
Journal:  Immunology       Date:  1979-06       Impact factor: 7.397

6.  Effect of late administration of anti-TNF alpha antibodies on a Salmonella infection in the mouse model.

Authors:  P Mastroeni; B Villarreal-Ramos; C E Hormaeche
Journal:  Microb Pathog       Date:  1993-06       Impact factor: 3.738

7.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.

Authors:  V Kindler; A P Sappino; G E Grau; P F Piguet; P Vassalli
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

8.  Immunity to Salmonella typhimurium infection in C3H/HeJ and C3H/HeNCrlBR mice: studies with an aromatic-dependent live S. typhimurium strain as a vaccine.

Authors:  L M Killar; T K Eisenstein
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

Review 9.  Pathogenesis and immunity in murine salmonellosis.

Authors:  H S Hsu
Journal:  Microbiol Rev       Date:  1989-12

10.  The comparative histopathology of primary and secondary lesions in murine salmonellosis.

Authors:  I Nakoneczna; H S Hsu
Journal:  Br J Exp Pathol       Date:  1980-02
View more
  32 in total

1.  Cytokines in Salmonella infection.

Authors:  I Trebichavský
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

Review 2.  A dynamic view of the spread and intracellular distribution of Salmonella enterica.

Authors:  Pietro Mastroeni; Andrew Grant; Olivier Restif; Duncan Maskell
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

Review 3.  Antibodies and Protection in Systemic Salmonella Infections: Do We Still Have More Questions than Answers?

Authors:  Pietro Mastroeni; Omar Rossi
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

4.  DTPA Fe(III) decreases cytokines and hypotension but worsens survival with Escherichia coli sepsis in rats.

Authors:  Yan Li; Xuemei Li; Michael Haley; Yvonne Fitz; Eric Gerstenberger; Steven M Banks; Peter Q Eichacker; Xizhong Cui
Journal:  Intensive Care Med       Date:  2006-06-15       Impact factor: 17.440

5.  Th1 and Th2 cell involvement in immune response to Salmonella typhimurium porins.

Authors:  M Galdiero; L De Martino; A Marcatili; I Nuzzo; M Vitiello; G Cipollaro de l'Ero
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

6.  Neutrophils prevent extracellular colonization of the liver microvasculature by Salmonella typhimurium.

Authors:  J W Conlan
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

7.  Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets.

Authors:  Jessica R Hitchcock; Charlotte N Cook; Saeeda Bobat; Ewan A Ross; Adriana Flores-Langarica; Kate L Lowe; Mahmood Khan; C Coral Dominguez-Medina; Sian Lax; Manuela Carvalho-Gaspar; Stefan Hubscher; G Ed Rainger; Mark Cobbold; Christopher D Buckley; Tim J Mitchell; Andrea Mitchell; Nick D Jones; N Van Rooijen; Daniel Kirchhofer; Ian R Henderson; David H Adams; Steve P Watson; Adam F Cunningham
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

8.  Intracellular adhesion molecule 1 plays a key role in acquired immunity to salmonellosis.

Authors:  Simon Clare; Robert Goldin; Christine Hale; Richard Aspinall; Cameron Simmons; Pietro Mastroeni; Gordon Dougan
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  Redundancy in tumor necrosis factor (TNF) and lymphotoxin (LT) signaling in vivo: mice with inactivation of the entire TNF/LT locus versus single-knockout mice.

Authors:  Dmitry V Kuprash; Marat B Alimzhanov; Alexei V Tumanov; Sergei I Grivennikov; Alexander N Shakhov; Ludmila N Drutskaya; Michael W Marino; Regina L Turetskaya; Arthur O Anderson; Klaus Rajewsky; Klaus Pfeffer; Sergei A Nedospasov
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

10.  Virulent Salmonella enterica infections can be exacerbated by concomitant infection of the host with a live attenuated S. enterica vaccine via Toll-like receptor 4-dependent interleukin-10 production with the involvement of both TRIF and MyD88.

Authors:  Gemma L Foster; Tom A Barr; Andrew J Grant; Trevelyan J McKinley; Clare E Bryant; Andrew MacDonald; David Gray; Masahiro Yamamoto; Shizuo Akira; Duncan J Maskell; Pietro Mastroeni
Journal:  Immunology       Date:  2008-02-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.